Home/Filings/4/0001127602-19-006793
4//SEC Filing

La Roche Elaine 4

Accession 0001127602-19-006793

CIK 0000062709other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:16 PM ET

Size

7.8 KB

Accession

0001127602-19-006793

Insider Transaction Report

Form 4
Period: 2019-02-15
Transactions
  • Award

    Restricted Stk. Units-Dir. Stk. Plan

    2019-02-15$90.35/sh+99.61$9,0008,080.9 total
    Common Stock (99.61 underlying)
  • Other

    Restricted Stk. Units-Dir. Stk. Plan

    2019-02-15$90.35/sh+36.66$3,3128,117.56 total
    Common Stock (36.66 underlying)
Footnotes (4)
  • [F1]The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
  • [F2]Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
  • [F3]Not Applicable.
  • [F4]Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.

Issuer

MARSH & MCLENNAN COMPANIES, INC.

CIK 0000062709

Entity typeother

Related Parties

1
  • filerCIK 0001540480

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:16 PM ET
Size
7.8 KB